We help turn science into therapies & products into business.
Articles of Interest
Opportunities in Regenerative Medicine: The Global Industry and Market Trends BioProcess International March 2011 Supplement
Successful Business Models for Cell-Based Therapies. 2008 World Stem Cell Report. 158-162.
Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole?. Regenerative Medicine. (2008) 3(6). 925-937.
The need for a regen industry voice. Regenerative Medicine, September 2008, Vol. 3, No. 5, Pages 621-631.
Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regenerative Medicine, November 2008, Vol. 3, No. 6, Pages 925-937
How the EU can fund your company. 17 November 2006, doi:10.1038/bioent914
The strong financial case for regenerative medicine and the regen industry. Regenerative Medicine
Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole?. Regenerative Medicine. (2008) 3(6). 925-937.
The need for a regen industry voice. Regenerative Medicine, September 2008, Vol. 3, No. 5, Pages 621-631.
Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regenerative Medicine, November 2008, Vol. 3, No. 6, Pages 925-937
How the EU can fund your company. 17 November 2006, doi:10.1038/bioent914
The strong financial case for regenerative medicine and the regen industry. Regenerative Medicine
(2008) 3(3) 351-363
A brief definition of regenerative medicine. Regenerative Medicine(2008) 3(1) 1–5
BSI Regenerative Medicine Glossary of Terms
Regenerative Medicine 2.0 (RegenMed 2.0) Regenerative Medicine(2007. 2(1), 11-18.
Great Expectations: Private Sector Activity in Tissue Engineering, Regenerative Medicine, and Stem Cell Therapeutics - M. Lysaght, et al
PAS 83 Guidance on codes of practice, standardised methods and regulations for cell-based therapeutics – from basic research to clinical application
A brief definition of regenerative medicine. Regenerative Medicine(2008) 3(1) 1–5
BSI Regenerative Medicine Glossary of Terms
Regenerative Medicine 2.0 (RegenMed 2.0) Regenerative Medicine(2007. 2(1), 11-18.
Great Expectations: Private Sector Activity in Tissue Engineering, Regenerative Medicine, and Stem Cell Therapeutics - M. Lysaght, et al
PAS 83 Guidance on codes of practice, standardised methods and regulations for cell-based therapeutics – from basic research to clinical application